N@N

NeuroMetrix to Present at Canaccord Genuity 5th Cardiovascular, Diabetes & Obesity Conference

_{//health-fitness.news-articles.net/content/2010/ .. -cardiovascular-diabetes-obesity-conference.html}
^{Published in Health and Fitness on Tuesday, November 30th 2010 at 14:11 GMT by Market Wire}  

WALTHAM, Mass.--([ BUSINESS WIRE ])--NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced that Shai Gozani, CEO, will be presenting at the Canaccord Genuity 5^th Cardiovascular, Diabetes & Obesity Conference at the Nikko Hotel, San Francisco, CA on December 8, 2010.

NeuroMetrix's presentation is scheduled for Wednesday, December 8, 2010 at 3:00 pm (EDT). A live audio webcast will be available on the investor relations section of our corporate website - [ www.neurometrix.com ]. This webcast will be archived after the live event.

About NeuroMetrix

NeuroMetrix is a science-based health care company transforming patient care through neurotechnology. We provide innovative products for preservation and restoration of nerve and spinal cord function, and pain control. To date, our focus has been primarily on the assessment of neuropathies. Neuropathies affect the peripheral nerves and parts of the spine and are frequently caused by or associated with carpal tunnel syndrome, diabetes, sciatica, and other clinical disorders. We market systems for the performance of nerve conduction studies and needle electromyography procedures. Our product pipeline includes a system designed to deliver pharmacologic agents such as anesthetics and corticosteroids in close proximity to nerves for regional anesthesia, pain control, and the treatment of focal neuropathies. We are also developing devices and pharmaceutical agents to treat peripheral nerve and spinal cord injuries. For more information, visit [ www.neurometrix.com ].